Rearrangement of PAX5 is observed in 2.5% of B-cell precursor ALL, with particular emphasis on the PAX5::JAK2 fusion, which plays an important role in tumorigenesis [111,112]. Here, PAX5 is linked to acute lymphoblastic leukemia.